10:34 AM EST - Oncolytics Biotech Inc. : Has entered into an agreement with Leede Jones Gable Inc. as underwriter and bookrunner, pursuant to which the Underwriter has agreed to purchase, on a bought-deal basis, 6,667,000 units for gross proceeds to the Company of US$15,000,750 at a price of US$2.25 per Equity Unit. Oncolytics Biotech Inc.
shares T.ONC are trading down $0.57 at $3.13.
